Marimed (MRMD) Current Deferred Revenue (2011 - 2026)

Marimed (MRMD) has 12 years of Current Deferred Revenue data on file, last reported at $1.5 million in Q1 2026.

• On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.4 million, up 4.89% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $1.5 million, up from $1.4 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for MRMD reached as high as $1.7 million in Q3 2025 and fell as low as $1.3 million in Q4 2024.
• Historically, Current Deferred Revenue has averaged $1.5 million across 3 years, with a median of $1.4 million in 2025.
• On a YoY basis, Current Deferred Revenue climbed as much as 4.89% in 2025 and fell as far as 4.89% in 2025.
• Year by year, Current Deferred Revenue stood at $1.3 million in 2024, then rose by 4.89% to $1.4 million in 2025, then advanced by 5.67% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $1.5 million in Q1 2026, $1.4 million in Q4 2025, and $1.7 million in Q3 2025.